(Q44124198)

30 November 2017

title

Efalizumab in routine use: a clinical experience (English)

1 reference

30 November 2017

N Selenko-Gebauer

1

1 reference

30 November 2017

F Karlhofer

series ordinal

2

1 reference

30 November 2017

G Stingl

series ordinal

3

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

British Journal of Dermatology

30 November 2017

published in

1 reference

30 November 2017

volume

156 Suppl 2

1 reference

30 November 2017

page(s)

1-6

1 reference

Psoriasis causes as much disability as other major medical diseases

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07762.X

T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07762.X

Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07762.X

Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07762.X

CLinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07762.X

Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07762.X

Comparative tolerability of systemic treatments for plaque-type psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07762.X

Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07762.X

Efalizumab: a review of events reported during clinical trials and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07762.X

Randomized Clinical Trials for Psoriasis 1977–2000: The EDEN Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07762.X

10.1111/J.1365-2133.2007.07762.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference